Stockscreener 앱 받기
0.2698
2.95%
-0.0082
시간 외 거래:
.27
0.0002
+0.07%
Ensysce Biosciences Inc 주식(ENSC)의 최신 뉴스
ENSC Should I Buy - Intellectia AI
Ensysce Biosciences Slips 3.94% as Stock Tests Key Support at $0.23New Listing Stocks - newsline.com
ENSC Q1 2026 Earnings: Narrowing Losses Signal Progress Amid Market VolatilityEarnings Acceleration Picks - The League of Women Voters of Texas
ENSC News | ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC) - ChartMill
Ensysce Biosciences Files for Sale of 1.3 Million Shares - Moomoo
Ensysce Biosciences (NASDAQ: ENSC) registers up to 1.3M shares for resale - Stock Titan
ENSC Q1 2026 Earnings: Narrower-Than-Expected Loss Despite No RevenueEarnings Whisper Number - The Legal Advocate
ENSC Q1 2026 Earnings: Narrower-than-expected loss boosts sharesMargin Guidance - newsline.com
Ensysce Biosciences (ENSC) Drops 3% as Stock Nears Support at $0.28MA Crossover - The Legal Advocate
Ensysce Biosciences (ENSC) Declines Further, Tests Key Support Near $0.29Diamond Pattern - Newser
Ensysce Faces New Nasdaq Issue as Deadline Nears - Bez Kabli
ENSC Q1 2026 Earnings: Narrower-than-expected Net Loss as EPS Beats EstimatesSegment Revenue Breakdown - The Legal Advocate
Ensysce Biosciences, Inc. Files Form 8-K: Company Details, Nasdaq Listing, and Compliance Update - Minichart
Ensysce Biosciences receives Nasdaq notice for non-compliance with equity rule - Investing.com
Ensysce Biosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Ensysce Biosciences (NASDAQ: ENSC) warned on Nasdaq equity listing rule - Stock Titan
Ensysce Biosciences : Corporate Overview - marketscreener.com
ENSC Advancing Testing and Expanding Potential - Yahoo Finance
Ensysce Biosciences (ENSC) Rallies +0.54% as Bulls Target $0.29 2026-05-18OBV Divergence - Newser
Ensysce Biosciences (ENSC) Crushes Q1 2026 Estimates — EPS $-0.52 Tops ViewsCFO Commentary Report - The Legal Advocate
Press Releases about Ensysce Biosciences, Inc.Common Stock - The Chronicle-Journal
Ensysce Biosciences, Inc.Common Stock (Nasdaq:ENSC) Stock Quote - The Chronicle-Journal
Ensysce Biosciences (ENSC) price target decreased by 34.79% to 16.78 - MSN
Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ensysce biosciences launches formal review of strategic alternativesSEC filing - marketscreener.com
Ensysce Biosciences Launches Formal Review Of Strategic AlternativesSEC Filing - TradingView
Ensysce Biosciences : Earnings Release Q1 2026 - marketscreener.com
ENSC: Clinical milestones and new financing highlight Q1 2026 amid ongoing R&D-driven losses - TradingView
Wider Q1 loss leaves Ensysce (NASDAQ: ENSC) with limited cash runway - Stock Titan
Ensysce Biosciences (ENSC) posts Q1 2026 loss, cash squeeze and strategic review - Stock Titan
This biotech is testing an opioid designed to limit overdose risk - Stock Titan
ENSC Q1'26 Earnings: EPS estimate is (0.73) USD - TradingView
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Nasdaq most active stocks: - MSN
TradingKey - TradingKey
Ensysce receives Taiwan patent for overdose protection technology - Investing.com UK
Ensysce receives Taiwan patent for overdose protection technology By Investing.com - Investing.com South Africa
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology - Corsicana Daily Sun
Opioid overdose-protection tech MPAR gets Taiwan patent to 2042 - Stock Titan
Sold 🍀🤞🏻 - Moomoo
$Ensysce Biosciences (ENSC.US)$ something in the milk aint clean…LG - Moomoo
MSN Money - MSN
Ensysce Biosciences Inc expected to post a loss of 73 cents a shareEarnings Preview - TradingView
Why are smart money investors paying attention to Ensysce Biosciences (ENSC)? (Tumbles Hard) 2026-05-08Wall Street Picks - Newser
Ensysce CEO outlines abuse-resistant opioid approach in Amsterdam - Stock Titan
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam - Corsicana Daily Sun
ENSC Ensysce Biosciences reports narrower Q4 2025 loss than estimates, shares climb after earnings release.Senior Analyst Forecasts - newser.com
ENSC - Finviz
Ensysce Biosciences (ENSC) Sector Trends | Q4 2025: EPS Beats ForecastsCommunity Chart Signals - UBND thành phố Hải Phòng
2.60%
0.94%
자본화:
|
볼륨(24시간):